Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Clinical trial NCT04211259 · RECRUITING
Trial details
- NCT number
- NCT04211259
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-18
- Primary completion
- 2026-08-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.